SA PRO
Free Account
NPBNPB
LOADING
|||
OverviewNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
1 analyst·Low coverage
100%
Rating Distribution
Strong Buy
00%
Buy
1100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Current price is 41% above analyst consensus — significant downside expected.

Bear Case
$7.00
-60%
Consensus
$10.20
-41%
Bull Case
$20.00
+16%
Price Range1 analyst
Low
Consensus
High
$7.00
$20.00
Current Target
Current Price
$17.30
Above Target
$7.10

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$2.69(2 analysts)
P/E56x
Current: 55.7x
Actual
Estimate
Range (Low–High)
Stock Alarm Pro
Forward Growth Estimates (YoY)
FY2027
Rev+7.51%
EPS+9.65%

Earnings Surprises

Beat rate:64%(7/11 quarters)
Avg surprise:+12.2%
Beat
Miss
Inline
Estimate
Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Dec 22, 2025Piper Sandler
Northpointe price target raised to $20 from $19.50 at Piper Sandler
Target:$20.00
+17.6%from $17.00
Oct 27, 2025H.C. Wainwright
H.C. Wainwright Reiterates Buy Rating on I-Mab (IMAB)
Target:$7.00
+55.0%from $4.52
Oct 8, 2025Piper Sandler
Northpointe price target raised to $19.50 from $17.50 at Piper Sandler
Target:$19.50
+11.4%from $17.51
Oct 3, 2025Leerink Partners
I-Mab initiated with an Outperform at Leerink
Target:$9.00
+117.9%from $4.13
Sep 10, 2025New Street
BTIG says buy I-Mab amid 'misperceived' China risk
Target:$7.00
+67.5%from $4.18
Aug 28, 2025Loop Capital Markets
I-Mab (IMAB) PT Raised to $8 at Brookline Capital Markets
Target:$8.00
+88.2%from $4.25

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance